Bio Palette Strengthens Leadership Team with Key Appointments: Kazuko Ando as
Executive Officer and CBO, Yoshinori Bamba as Executive Officer and COO, and Shinji
Maeda as Auditor
Kobe, Japan -January 17, 2024
FOR IMMEDIATE RELEASE
Bio Palette Co., Ltd. (Head Office: Chuo-ku, Kobe City) under the leadership of Dr. Ryo Okumura as CEO, isthrilled to announce significant additions to its executive team and the appointment of a new auditor. Thesestrategic changes will strengthen the management framework and bolster governance of Bio Palette, aligningwith our vision for growth and innovation.

Name

Job Title

Appointed date

Kazuko Ando

Executive Officer CBO（Chief Business Officer）

November 24, 2023

Yoshinori Bamba

Executive Officer COO（Chief Operating Officer）

January 1 2024

Shinji Maeda

AuditorDecember 22, 2023

Kazuko Ando, a distinguished professional in the industry, commenced her journey with Bio Palette as the
Executive Officer and Chief Business Officer in November 2023. Before joining our team, Ms. Ando showcased
her exceptional abilities as the Executive VP Head of Legal and Business Development at Healios NA, Inc.
from 2022, a subsidiary of HEALIOS K.K. Her illustrious career at Healios, spanning from 2014, culminatedin her leadership of the Legal Group and Business Development. Before Healios, Ms. Ando honed her expertisein intellectual property at GREE, Inc., Sony Corporation, and Suntory Holding Limited, obtaining her patent
attorney certification in 2006. Ms. Ando holds a master's degree from Osaka University, where she was the top
Biological Sciences graduate in 2001. Her extensive experience encompasses pivotal roles in major corporations
and biotech ventures, focusing on intellectual property, legal affairs, and business development.
Yoshinori Bamba, the newly appointed Chief Operating Officer at Bio Palette, assumed his role in January 2024.
Prior to joining our team, Mr. Bamba was a director at PURMX Therapeutics, Inc., where he oversaw businessdevelopment and fundraising efforts. At J-Pharma Co., Ltd., his responsibilities included devising effective
business strategies and successfully leading the out-licensing of in-house developed compounds to otherpharmaceutical companies. Earlier in his career, he played a pivotal role in product launches at CSL Behring
K.K.. Mr. Bamba's professional journey began at Kyowa Kirin Co., Ltd., where he contributed to the launch of
two drugs while focusing on pharmacokinetics and clinical pharmacology. His academic accomplishments

include a master's degree from the Tokyo University of Pharmacy and Life Sciences in 2007 and an MBA in
2013. His expertise spans pharmaceutical development, particularly in pharmacokinetics and clinicalpharmacology, along with a wealth of experience in management, strategy, and business development within
the biotech sector.
Shinji Maeda assumed the role of auditor at Bio Palette in December 2023. Mr. Maeda, the founder, and CEOof Umegae Central Accounting Co., Ltd. since 2014, brings invaluable experience to our organization. Before
this, he served as a senior manager at Asahi Audit Corporation, now KPMG AZSA LLC, and holds registrations
as a certified public and tax accountant. Mr. Maeda graduated from Osaka University's School of Economics in1994 and is renowned for his contributions to the field, including publications on accounting and taxation anduniversity lectures on corporate ethics and finance. His comprehensive background is expected to benefit Bio
Palette's financial integrity and governance greatly.
With the appointment of these esteemed individuals to our executive team and the addition of Mr. Maeda as anauditor, Bio Palette is poised to further strengthen our organizational structure and expansion. Our unwaveringcommitment to innovation in microbiome therapeutics, driven by our unique genome editing technology,
remains steadfast. We are dedicated to applying this pioneering technology across various business sectors. Bio
Palette will continue actively recruiting talent across administrative, research, and development departments,
with our management team working collectively to achieve our ambitious goals.
For inquiries regarding this release, please contact us at:
Bio Palette Co., Ltd.
Email: contact@biopalette.co.jp
About Bio Palette Co., Ltd.:
Bio Palette is a leading biotechnology company headquartered in Kobe, Japan, dedicated to revolutionizing
healthcare through innovative microbiome therapeutics powered by cutting-edge genome editing technology.
Our mission is to harness the potential of the microbiome to improve human health and quality of life. Learn
more at www.biopalette.co.jp.